Civic Intelligence

Central Pa Transplant Foundatn Inc

EIN 25-1857128 • 501(c)3 • Harrisburg, PA

Profile

To promote and foster advances in transplantation thru activities that have included participation in clinical trials investigating different immunosuppressive regimens, development of clinical pathways to enhance patient care, forums for public and physician education in transplanta- tion, studies related to outcomes research, laboratory work in immunobiology and new concepts in diabetes management.

205 S Front St 8th FL Brady BldgHarrisburg, PA 17104

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

84th percentile

0.24x

Higher debt load relative to assets than 84% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

85th percentile

0.14x

Higher debt load relative to revenue than 85% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

49th percentile

1.2%

Higher net margin than 49% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

82nd percentile

35%

Faster asset growth than 82% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

34th percentile

-19%

Faster revenue growth than 34% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets84th percentile

Assets

Down

$55,219

Down $39,831 (-42%) from 2022

Liabilities

Down

$13,116

Down $32,939 (-72%) from 2022

Net Assets

Down

$42,103

Down $6,892 (-14%) from 2022

Operations
Liabilities / Revenue85th percentileNet Margin49th percentile

Revenue

Up

$95,592

Up $43,370 (+83%) from 2022

Expenses

Down

$94,443

Down $26,569 (-22%) from 2022

Net Income

Up

$1,149

Up $69,939 (+102%) from 2022

Trend Graphs

Balance Sheet Trend

Asset Growth82nd percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$800K$600K$400K$200K$0Assets 2010: $607,182Liabilities 2010: $18Net Assets 2010: $607,1642010Assets 2013: $467,745Liabilities 2013: $18Net Assets 2013: $467,7272013Assets 2014: $296,732Liabilities 2014: $18Net Assets 2014: $296,7142014Assets 2015: $367,512Liabilities 2015: $18Net Assets 2015: $367,4942015Assets 2016: $308,611Liabilities 2016: $18Net Assets 2016: $308,5932016Assets 2017: $196,544Liabilities 2017: $0Net Assets 2017: $196,5442017Assets 2019: $136,418Liabilities 2019: $0Net Assets 2019: $136,4182019Assets 2020: $115,147Liabilities 2020: $0Net Assets 2020: $115,1472020Assets 2021: $117,785Liabilities 2021: $0Net Assets 2021: $117,7852021Assets 2022: $95,050Liabilities 2022: $46,055Net Assets 2022: $48,9952022Assets 2024: $55,219Liabilities 2024: $13,116Net Assets 2024: $42,1032024

Highlighted filing

2024

Assets$55,219
Liabilities$13,116
Net Assets$42,103
Open 2024 Filing

Operations Trend

Revenue Growth34th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$200K$0-$200KExpenses 2010: $192,6932010Revenue 2013: $144,185Expenses 2013: $209,390Net Income 2013: -$65,2052013Revenue 2014: $105,579Expenses 2014: $276,592Net Income 2014: -$171,0132014Revenue 2015: $88,216Expenses 2015: $17,436Net Income 2015: $70,7802015Revenue 2016: $111,075Expenses 2016: $169,976Net Income 2016: -$58,9012016Revenue 2017: $101,319Expenses 2017: $213,368Net Income 2017: -$112,0492017Revenue 2019: $37,224Expenses 2019: $65,020Net Income 2019: -$27,7962019Revenue 2020: $109,339Expenses 2020: $130,610Net Income 2020: -$21,2712020Revenue 2021: $150,336Expenses 2021: $147,698Net Income 2021: $2,6382021Revenue 2022: $52,222Expenses 2022: $121,012Net Income 2022: -$68,7902022Revenue 2024: $95,592Expenses 2024: $94,443Net Income 2024: $1,1492024

Highlighted filing

2024

Revenue$95,592
Expenses$94,443
Net Income$1,149
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.

Open filing
Assets
$55,219
Liabilities
$13,116
Net assets
$42,103
Revenue
$95,592
Expenses
$94,443
Net income
$1,149
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.55$0.13$0.42$0.96$0.94$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.95$0.46$0.49$0.52$1.21$0.69
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.18$0.00$1.18$1.50$1.48$0.03
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.15$0.00$1.15$1.09$1.31$0.21
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.36$0.00$1.36$0.37$0.65$0.28
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.97$0.00$1.97$1.01$2.13$1.12
2016Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.09$0.00$3.09$1.11$1.70$0.59
2015Detailed filing. Detailed filing data is available for this year.$3.68$0.00$3.67$0.88$0.17$0.71
2014Detailed filing. Detailed filing data is available for this year.$2.97$0.00$2.97$1.06$2.77$1.71
2013Detailed filing. Detailed filing data is available for this year.$4.68$0.00$4.68$1.44$2.09$0.65
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.00$6.07$1.93
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 9, 2025
Return Version
2024v5.0
Gross Receipts
$112,353
Mission and Program Overview

Mission

To promote and foster advances in transplantation thru activities that have included participation in clinical trials investigating different immunosuppressive regimens, development of clinical pathways to enhance patient care, forums for public and physician education in transplanta- tion, studies related to outcomes research, laboratory work in immunobiology and new concepts in diabetes management.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$40,954$42,103▲ $1,149
Investments in Publicly Traded Securities$8,972$27,470▲ $18,498
Land, Buildings, and Equipment, Net$27,729$19,299▼ $8,430
Cash and Non-Interest-Bearing Accounts$4,253--
Total Assets$40,954$55,219▲ $14,265
Other Assets Total-$8,450-
Liabilities
Other Liabilities-$13,116-
Total Liabilities$0$13,116▲ $13,116
Net Assets / Fund Balance
Total Net Assets Fund Balance$40,954$42,103▲ $1,149
Total Liabilities and Net Assets / Fund Balance$40,954$55,219▲ $14,265

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$46,611-$46,611
Equipment$-27,312$27,312-
Other Assets Org$8,450--
Compensation and Service Providers
Top Officer Pay81st percentile

Board Members and Trustees

NameTitle
Harold C Yang MdPresident
Jonathan R DiamondDirector
Mary M WaybillPhysician
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$10,282
Investment Income
$85,310
Other Revenue
$0
Change in Net Assets
$1,149
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$94,443
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Depreciation Depletion$8,430--$8,430
All Other Expenses$372$6,781-$7,153
Other Expenses$40,984$7,005-$7,005
Travel$4,832--$4,832
Fees for Services Accounting-$550-$550
Total Functional Expenses$54,618$39,825$0$94,443
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Cash Overdraft$13,116
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“Approved by treasurer before submission.”

Form 990, Page 6, Part VI, Line 19

“UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Central Pa Transplant Foundatn Inc
EIN
25-1857128
Phone
7172318804
Address
205 S FRONT ST 8TH FL BRADY BLDG, HARRISBURG, PA 17104

Signing Officer

Name
Harold C Yang Md
Title
President
Phone
7172318400
Signed
2025-05-09

Organization Details

Principal Officer
Harold C Yang Md
Voting Board Members
3
Independent Board Members
2
Employees
0

Preparer

Firm
Add Accounting Inc
Address
7 W MAIN ST, SHIREMANSTOWN, PA 17011
Preparer
Andrew Donnelly
Phone
7177636890
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“To promote and foster advances in transplantation thru activities that have included participation in clinical trials investigating different immunosuppressive regimens, development of clinical pathways to enhance patient care, forums for public and physician education in transplanta- tion, studies related to outcomes research, laboratory work in immunobiology and new concepts in diabetes management.”

Form 990, Page 2, Part III, Line 4D

“Depreciation on assets used in research.”

Raw XML Appendix308 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0TO PROMOTE AND FOSTER ADVANCES IN TRANSPLANTATION THRU ACTIVITIES THAT HAVE INCLUDED PARTICIPATION IN CLINICAL TRIALS INVESTIGATING DIFFERENT IMMUNOSUPPRESSIVE REGIMENS, DEVELOPMENT OF CLINICAL PATHWAYS TO ENHANCE PATIENT CARE, FORUMS FOR PUBLIC AND PHYSICIAN EDUCATION IN TRANSPLANTA- TION, STUDIES RELATED TO OUTCOMES RESEARCH, LABORATORY WORK IN IMMUNOBIOLOGY AND NEW CONCEPTS IN DIABETES MANAGEMENT.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt06781
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0372
IRS990/AllOtherExpensesGrp/TotalAmt07153
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0HARRY C YANG MD
IRS990/BooksInCareOfDetail/PhoneNum07172318804
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0205 S FRONT ST
IRS990/BooksInCareOfDetail/USAddress/AddressLine2Txt0BRADY 8
IRS990/BooksInCareOfDetail/USAddress/CityNm0HARRISBURG
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd017104
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt04253
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt085310
IRS990/CYOtherExpensesAmt094443
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt010282
IRS990/CYRevenuesLessExpensesAmt01149
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt094443
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt095592
IRS990/DAFExcessBusinessHoldingsInd0false
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt08430
IRS990/DepreciationDepletionGrp/TotalAmt08430
IRS990/Desc01. VITAERIS PROTOCOL VKTX01 "A PIVOTAL PHASE 3 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF CLAZAKIZUMAB FOR THE TREATMENT OF CHRONIC ACTIVE-MEDICATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS". APRIL 2019-DECEMBER 2024. 2. APOL 1 LONG-TERM KIDNEY TRANSPLANTATION OUTCOMES NETWORK PROTOCOL SUMMARY FOR NON-ENGAGED SITES (APOLLO) NIH SPONSORED. MARCH 2020-PRESENT. 3. NATERA PROTOCOL 20-048-TRP "RENASIGHT CLINICAL APPLICATION, REVIEW, AND EVALUATION (RENACARE) STUDY DECEMBER 2021-JULY 2024. 4. ELEDON BESTOW PROTOCOL AT-1501-K207 "A PHASE 2, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TEGOPRUBART IN PATIENTS UNDERGOING KIDNEY TRANSPLANTATION" AUGUST 2023-PRESENT (ACTIVE).
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DistributionToDonorInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt046188
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0550
IRS990/FeesForServicesAccountingGrp/TotalAmt0550
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form1098CFiledInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form8899Filedind0false
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0JONATHAN R DIAMOND
IRS990/Form990PartVIISectionAGrp/PersonNm1HAROLD C YANG MD
IRS990/Form990PartVIISectionAGrp/PersonNm2MARY M WAYBILL
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2PHYSICIAN
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt085238
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0101999
IRS990/GrossReceiptsAmt0112353
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt02
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt072
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt072
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt08972
IRS990/InvestmentsPubTradedSecGrp/EOYAmt027470
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt027312
IRS990/LandBldgEquipBasisNetGrp/BOYAmt027729
IRS990/LandBldgEquipBasisNetGrp/EOYAmt019299
IRS990/LandBldgEquipCostOrOtherBssAmt046611
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt016761
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0TO PROMOTE AND FOSTER ADVANCES IN TRANSPLANTATION THRU ACTIVITIES THAT HAVE INCLUDED PARTICIPATION IN CLINICAL TRIALS INVESTIGATING DIFFERENT IMMUNOSUPPRESSIVE REGIMENS, DEVELOPMENT OF CLINICAL PATHWAYS TO ENHANCE PATIENT CARE, FORUMS FOR PUBLIC AND PHYSICIAN EDUCATION IN TRANSPLANTA- TION, STUDIES RELATED TO OUTCOMES RESEARCH, LABORATORY WORK IN IMMUNOBIOLOGY AND NEW CONCEPTS IN DIABETES MANAGEMENT.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt040954
IRS990/NetAssetsOrFundBalancesEOYAmt042103
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt085238
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt085238
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherAssetsTotalGrp/EOYAmt08450
IRS990/OtherExpensesGrp/Desc0MEDICAL PROFESSIONALS
IRS990/OtherExpensesGrp/Desc1OFFICE EXPENSE
IRS990/OtherExpensesGrp/Desc2MEALS & ENTERTAINMENT
IRS990/OtherExpensesGrp/Desc3GIFTS/PROMOTION
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt013872
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt111617
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt27005
IRS990/OtherExpensesGrp/ProgramServicesAmt040984
IRS990/OtherExpensesGrp/TotalAmt040984
IRS990/OtherExpensesGrp/TotalAmt113872
IRS990/OtherExpensesGrp/TotalAmt211617
IRS990/OtherExpensesGrp/TotalAmt37005
IRS990/OtherLiabilitiesGrp/EOYAmt013116
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0HAROLD C YANG MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0TRANPLANTATION RESEARCH
IRS990/ProgramServiceRevenueGrp/ExclusionAmt010282
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt010282
IRS990/ProgSrvcAccomActyOtherGrp/Desc0DEPRECIATION ON ASSETS USED IN RESEARCH.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt08430
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt097508
IRS990/PYOtherExpensesAmt0126281
IRS990/PYProgramServiceRevenueAmt020732
IRS990/PYRevenuesLessExpensesAmt0-8041
IRS990/PYTotalExpensesAmt0126281
IRS990/PYTotalRevenueAmt0118240
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt01149
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0true
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt010282
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt040954
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt042103
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0OTHER INCOME 5,373
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART II, LINE 10
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt010282
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt020732
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt029169
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt030720
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt015174
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0106077
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt072
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0277
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0241
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt034
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0613
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01237
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt01237
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt010282
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt05373
IRS990ScheduleA/OtherIncome170Grp/TotalAmt015655
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.86260
IRS990ScheduleA/PublicSupportPY170Pct00.78140
IRS990ScheduleA/PublicSupportTotal170Amt0106077
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt010282
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt020732
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt029169
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt030720
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt015174
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0106077
IRS990ScheduleA/TotalSupportAmt0122969
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/EquipmentGrp/BookValueAmt0-27312
IRS990ScheduleD/EquipmentGrp/DepreciationAmt027312
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt08450
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0OTHER ASSETS
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt046611
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt046611
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt013116
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0CASH OVERDRAFT
IRS990ScheduleD/TotalBookValueLandBuildingsAmt019299
IRS990ScheduleD/TotalBookValueOtherAssetsAmt08450
IRS990ScheduleD/TotalLiabilityAmt013116
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0TO PROMOTE AND FOSTER ADVANCES IN TRANSPLANTATION THRU ACTIVITIES THAT HAVE INCLUDED PARTICIPATION IN CLINICAL TRIALS INVESTIGATING DIFFERENT IMMUNOSUPPRESSIVE REGIMENS, DEVELOPMENT OF CLINICAL PATHWAYS TO ENHANCE PATIENT CARE, FORUMS FOR PUBLIC AND PHYSICIAN EDUCATION IN TRANSPLANTA- TION, STUDIES RELATED TO OUTCOMES RESEARCH, LABORATORY WORK IN IMMUNOBIOLOGY AND NEW CONCEPTS IN DIABETES MANAGEMENT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DEPRECIATION ON ASSETS USED IN RESEARCH.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2APPROVED BY TREASURER BEFORE SUBMISSION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4D
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0PA
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxableDistributionsInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt040954
IRS990/TotalAssetsEOYAmt055219
IRS990/TotalAssetsGrp/BOYAmt040954
IRS990/TotalAssetsGrp/EOYAmt055219
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt039825
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt054618
IRS990/TotalFunctionalExpensesGrp/TotalAmt094443
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesEOYAmt013116
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt013116
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt040954
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt042103
IRS990/TotalOtherProgSrvcExpenseAmt08430
IRS990/TotalProgramServiceExpensesAmt054618
IRS990/TotalProgramServiceRevenueAmt010282
IRS990/TotalRevenueGrp/ExclusionAmt010282
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt085310
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt095592
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt040954
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt055219
IRS990/TravelGrp/ProgramServicesAmt04832
IRS990/TravelGrp/TotalAmt04832
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt02
IRS990/WebsiteAddressTxt0N/A
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/PersonNm0HAROLD C YANG MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum07172318400
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CENTRAL PA TRANSPLANT FOUNDATN INC
ReturnHeader/Filer/BusinessNameControlTxt0CENT
ReturnHeader/Filer/EIN0251857128
ReturnHeader/Filer/PhoneNum07172318804
ReturnHeader/Filer/USAddress/AddressLine1Txt0205 S FRONT ST 8TH FL BRADY BLDG
ReturnHeader/Filer/USAddress/CityNm0HARRISBURG
ReturnHeader/Filer/USAddress/StateAbbreviationCd0PA
ReturnHeader/Filer/USAddress/ZIPCd017104
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0873924813
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0ADD ACCOUNTING INC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt07 W MAIN ST
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SHIREMANSTOWN
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0PA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd017011
ReturnHeader/PreparerPersonGrp/PhoneNum07177636890
ReturnHeader/PreparerPersonGrp/PreparationDt02025-05-09
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ANDREW DONNELLY
ReturnHeader/ReturnTs02025-06-03T09:56:20-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.